✦ LIBER ✦

Efficacy of rituximab plus chemotherapy in follicular lymphoma depends on Ki-67 expression

✍ Scribed by Bungo Saito; Eisuke Shiozawa; Toshiko Yamochi-Onizuka; Daisuke Adachi; Tsuyoshi Nakamaki; Shigeru Tomoyasu; Mitsuhiro Omine; Toshiyuki Mitsuya; Masafumi Takimoto; Hidekazu Ota

Book ID: 115175366
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 281 KB
Volume: 54
Category: Article
ISSN: 1320-5463
DOI: 10.1111/j.1440-1827.2004.01678.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ki-67 expression as a prognostic factor

Ki-67 expression as a prognostic factor in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP

✍ Dok Hyun Yoon; Dae Ro Choi; Heui June Ahn; Shin Kim; Dae Ho Lee; Sang-We Kim; Bo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB

Rapid and sustained clearance of circula

Rapid and sustained clearance of circulating lymphoma cells after chemotherapy plus rituximab: clinical significance of quantitative t(14;18) PCR monitoring in advanced stage follicular lymphoma patients

✍ Carsten Hirt; Frank Schüler; Thomas Kiefer; Cornelia Schwenke; Antje Haas; Dietg 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 251 KB

Prognostic significance of Ki-67 nuclear

Prognostic significance of Ki-67 nuclear proliferative antigen, bcl-2 protein, and p53 expression in follicular and diffuse large B-cell lymphoma

✍ Marta Llanos; Hugo Alvarez-Argüelles; Remedios Alemán; Juana Oramas; Lucio Díaz- 📂 Article 📅 2001 🏛 Springer US 🌐 English ⚖ 98 KB

A prognostic model based on combining es

A prognostic model based on combining estrogen receptor expression and Ki-67 value after neoadjuvant chemotherapy predicts clinical outcome in locally advanced breast cancer: Extension and analysis of a previously reported cohort of patients

✍ Miglietta, L.; Morabito, F.; Provinciali, N.; Canobbio, L.; Meszaros, P.; Naso, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 674 KB